Pages that link to "Q47864743"

The following pages link to Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. (Q47864743):

Displaying 50 items.

• Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria (Q26772878) ‎ (← links)
• Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells (Q27230075) ‎ (← links)
• Host cell invasion by malaria parasites (Q27230084) ‎ (← links)
• The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7 (Q27230100) ‎ (← links)
• Structure of the C-terminal domains of merozoite surface protein-1 from Plasmodium knowlesi reveals a novel histidine binding site (Q27640198) ‎ (← links)
• Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate (Q27641117) ‎ (← links)
• Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes (Q27972789) ‎ (← links)
• Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes (Q27972792) ‎ (← links)
• Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase (Q27973702) ‎ (← links)
• A Plasmodium α/β-hydrolase modulates the development of invasive stages (Q27973903) ‎ (← links)
• The merozoite surface protein 1 complex is a platform for binding to human erythrocytes by Plasmodium falciparum (Q27974532) ‎ (← links)
• Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region (Q28345224) ‎ (← links)
• Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate (Q28748331) ‎ (← links)
• Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes (Q30042482) ‎ (← links)
• A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites (Q30043439) ‎ (← links)
• Functional characterization of the propeptide of Plasmodium falciparum subtilisin-like protease-1 (Q30043446) ‎ (← links)
• Systematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasite (Q30044844) ‎ (← links)
• Interaction between two domains of the P. yoelii MSP-1 protein detected using the yeast two-hybrid system (Q30714235) ‎ (← links)
• MSP-1 malaria pseudopeptide analogs: biological and immunological significance and three-dimensional structure. (Q31137274) ‎ (← links)
• Plasmodium falciparum merozoite surface protein 1. (Q33186178) ‎ (← links)
• Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children (Q33264521) ‎ (← links)
• Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria (Q33281394) ‎ (← links)
• Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses (Q33356029) ‎ (← links)
• Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites. (Q33532314) ‎ (← links)
• The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites (Q33558061) ‎ (← links)
• The malaria parasite cyclic GMP-dependent protein kinase plays a central role in blood-stage schizogony (Q33585913) ‎ (← links)
• Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. (Q33866742) ‎ (← links)
• Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum (Q33866986) ‎ (← links)
• Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys (Q34003578) ‎ (← links)
• Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19). (Q34003924) ‎ (← links)
• Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. (Q34007632) ‎ (← links)
• Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans (Q34081745) ‎ (← links)
• The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies (Q34131183) ‎ (← links)
• Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion (Q34131763) ‎ (← links)
• Advances and challenges in malaria vaccine development. (Q34145333) ‎ (← links)
• Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands (Q34180495) ‎ (← links)
• Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum (Q34334187) ‎ (← links)
• Limited polymorphism of the Plasmodium vivax merozoite surface protein 1 gene in isolates from Turkey (Q34341789) ‎ (← links)
• Regulated maturation of malaria merozoite surface protein‐1 is essential for parasite growth (Q34369560) ‎ (← links)
• Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes (Q34679952) ‎ (← links)
• Immunity to asexual blood stage malaria and vaccine approaches (Q34842236) ‎ (← links)
• Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity (Q34975629) ‎ (← links)
• Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum (Q35383761) ‎ (← links)
• Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria (Q35549892) ‎ (← links)
• Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds (Q35551944) ‎ (← links)
• Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. (Q35557657) ‎ (← links)
• Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development (Q35805390) ‎ (← links)
• Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines (Q35862464) ‎ (← links)
• Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates (Q35945359) ‎ (← links)
• Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination (Q36045018) ‎ (← links)